Pharmacokinetic Modeling Software - an overview | ScienceDirect Topics
Model-Informed Drug Development, Pharmacokinetic/Pharmacodynamic Cutoff Value Determination, and Antibacterial Efficacy of Benapenem against Enterobacteriaceae | Antimicrobial Agents and Chemotherapy
Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate | SpringerLink
What Is Population Pharmacokinetic (popPK) Analysis?
Analysis of pk data- Pop PK analysis
Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | SpringerLink
Pharmaceutics | Free Full-Text | Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure | HTML
Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance - Byon - 2013 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives - ScienceDirect
Population Pharmacokinetics Analysis of Quetiapine Extended-release Formulation in Japanese Patients with Bipolar Depression - Clinical Therapeutics
Analysis of pk data- Pop PK analysis
Food Effect Projections via Physiologically Based Pharmacokinetic Modeling: Predictive Case Studies - Journal of Pharmaceutical Sciences
Dosing of Continuous Fentanyl Infusions in Obese Children: A Population Pharmacokinetic Analysis | PKMS Lab | UBC
Development of a population pharmacokinetic model of olanzapine for Chinese health volunteers and patients with schizophrenia | BMJ Open
Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations
Development of a population pharmacokinetic model of olanzapine for Chinese health volunteers and patients with schizophrenia | BMJ Open
Simulation results using PK parameters obtained from PopPK analysis... | Download Scientific Diagram
Population PK/PD analysis: what, why, how and when - Insights From Our Labs to Yours
Population Pharmacokinetics of CC-122 | CPAA
Analysis of pk data- Pop PK analysis
Population PK/PD analysis: what, why, how and when - Insights From Our Labs to Yours
Noncompartmental vs. Compartmental PK Analysis
Combining “Bottom‐up” and “Top‐down” Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC‐0941) Pharmacokinetics - Lu - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
CHARACTERIZATION OF THE TIME-VARYING CLEARANCE OF RITUXIMAB IN NON-HODGKIN'S LYMPHOMA PATIENTS USING A POPULATION PHARMACOKINETIC ANALYSIS METHODS INTRODUCTION. - ppt download